Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05480696 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Soluble Fibre Supplementation in NAFLD

Study acronym: FIND
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Phase: Phase 1 to Phase 2 Collaborators shortened, about 6 wordsv4 Show 1 more changeShow less
    • Collaborators shortened, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Sep 2022 to Sep 9, 2022 · Interventions: Fructo-oligosaccharide supplement (Dietary Supplement), Maltodextrin (Other) to Fructo-oligosaccharide enriched inulin supplement (Dietary Supplement), Maltodextrin (Other) · 2 morev3 Show 5 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2022 to Sep 9, 2022
    • Interventions: Fructo-oligosaccharide supplement (Dietary Supplement), Maltodextrin (Other) to Fructo-oligosaccharide enriched inulin supplement (Dietary Supplement), Maltodextrin (Other)
    • Eligibility criteria expanded, about 9 words
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The FIND study will look at the effect of a nutritional mixed fibre supplement, oligofructose and inulin (OF+INU), on children with non-alcoholic fatty liver disease. In this randomized, double- blind controlled trial, subjects will be given a supplement, in the form of oral pills, and will have bloodwork performed, their diets analyzed, and liver fat measured at several timepoints. Liver fat will be measured by using a specialized MRI device located at St. Joseph's Hospital. Subjects will be recruited from the Children's Exercise and Nutrition Clinic.
Trial Details
NCT Number NCT05480696
Lead Sponsor McMaster University
Conditions Non-Alcoholic Fatty Liver Disease, Non Alcoholic Steatohepatitis, Hepatic Steatosis
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov